TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
EQ

Equillium Inc

Healthcare · Biotechnology

1.80$ -9.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow EQ
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +4,901.6% +276.9% +95.7% +60.0% +63.9% +6.8% +8.7% -15.3%
– – +409.6% +69.5% +15.5% +9.8% -17.4% -6.2% -38.1%
– +114.6% -25.5% +62.4% +28.1% +508.1% – – –
– -30.7% +136.9% +76.0% +35.3% -98.9% -13,500.0% – -375.2%
– +1,485.2% +112.3% +173.0% -71.8% +389.5% -82.1% +70.0% -43.5%
– +1,702,234.2% -94.2% +758.4% – -31.8% -125.5% – -67.7%
– – – – – – – – –
– +64,475,357.0% -100.2% – -97.9% -100.0% – – –
– -82.8% +517.9% -114.5% +0.0% +0.0% +539.1% -100.0% –
– +754.4% -85.2% +448.4% -42.4% -103.9% +659.5% – +18,453.0%
– +201.3% -171.4% – +145.1% -66.9% -510.6% – –
– – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?